Menu Close

AHCC® Research
AHCC®の研究

AHCC® is studied extensively at more than 100 leading institutions worldwide.

As a patented novel bioactive substance, AHCC® has been opening diverse scientific possibilities, for which we have been carrying out collaborative research projects with over 100 universities, hospitals and institutions worldwide.

 
Those basic and clinical study results on immunity, infectious disease, cancer, inflammatory disease and other fields have been published and presented globally. Also, the latest research results are presented at the annual meeting of International Congress on Nutrition and Integrative Medicine (ICNIM), where scientists, doctors and industry experts are gathering from all over the world.

Safety of AHCC®

AHCC® is confirmed to be nontoxic and safe food product by in vitro, in vivo, and clinical studies:

    • Reverse mutation test and micronucleus test (GLP study)
    • Single dose oral toxicity study in rats (GLP study)
    • 90-days repeated dose oral toxicity study in rats (non-GLP study)
    • Phase I clinical safety study (2 weeks)

 

Additionally, AHCC® is a natural compound derived from mushroom with a long history of human consumption. No adverse events have been reported since its launch in 1989.